Contextlogic Inc Ownership
| LOGC Stock | USD 7.70 0.05 0.65% |
Contextlogic Inc |
Contextlogic Inc OTC Stock Ownership Analysis
About 64.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Contextlogic Inc recorded a loss per share of 0.76. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 12th of April 2023. LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Logicbio Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 62 people.The quote for Contextlogic is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Contextlogic contact Rishi Bajaj at 415-965-8476 or learn more at https://ir.contextlogicinc.com.Contextlogic Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Contextlogic Inc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Contextlogic Inc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Contextlogic Inc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Contextlogic Inc Outstanding Bonds
Contextlogic Inc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Contextlogic Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Contextlogic Inc bonds can be classified according to their maturity, which is the date when Contextlogic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Contextlogic Inc OTC Stock
Contextlogic Inc financial ratios help investors to determine whether Contextlogic Inc OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Contextlogic Inc with respect to the benefits of owning Contextlogic Inc security.